MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Defective visual perception in patients with Lewy body disease: assessment of hallucinations with pareidolia test.

    Y. Higashi, T. Tabuchi, M. Tabata (Himeji, Japan)

    Objective: Hallucination is a common feature in patients with advanced Parkinson’s disease(PD) and dementia with Lewy bodies (DLB). Background: The pareidolia test is a tool…
  • 2017 International Congress

    Apolipoprotein E ε4 allele frequency in Korean Patients with Parkinson’s disease Dementia

    M. Park (Daegu, Republic of Korea)

    Objective: The Apo E allele frequencies were evaluated in Korean patients with probable PDD diagnosed by the MDS task force criteria for the diagnosis of…
  • 2017 International Congress

    The Effect of Anxiety on Cognition in Parkinson’s Disease

    S. Anderson, G. Stebbins, B. Bernard, A. Negron, J. Goldman (Chicago, IL, USA)

    Objective: Our study examined the effect of anxiety on cognition in Parkinson’s disease (PD) patients without cognitive impairment, mild cognitive impairment and dementia. Background: Anxiety…
  • 2017 International Congress

    CLOCK rs1801260 polymorphism is associated with suscepibilty of Parkinson’s disease in Chinese population

    F. Lou, X. Luo, M. Li, Y. Ren (Shenyang, China)

    Objective: This study is aimed at evaluating the potential association between the single-nucleotide polymorphism of two functional clock genes (CLOCK gene rs1801260 and PER2 gene…
  • 2017 International Congress

    Alteration of early endosomal trafficking causes neurodegeneration in PARK20

    C. Criscuolo, D. Fasano, V. Coppola, G. Amodio, M. Picillo, A. De Rosa, V. Bonifati, P. Barone, M. Pellecchia, G. De Michele, P. Remondelli, S. Paladino (Naples, Italy)

    Objective: To elucidate the molecular basis of the Park20 by evaluating the role of synaptojanin 1 in intracellular trafficking. Background: Recently a new form of…
  • 2017 International Congress

    Full sequencing and GWAS markers analysis of SNCA in RBD and progression to synucleinopathies.

    Z. Gan-Or, J. Ruskey, I. Arnulf, Y. Dauvilliers, B. Hogl, A. Stefani, C. Charley Monaca, P. Dion, A. Desautels, J.-F. Gagnon, N. Dupre, R. Postuma, J. Montplaisir, G. Rouleau (Montreal, QC, Canada)

    Objective: To study the role of SNCA variants in REM sleep Behavior Disorder (RBD) and progression to synucleinopathies. Background: Individuals with properly diagnosed idiopathic RBD…
  • 2017 International Congress

    Early-Onset Parkinsonism and Short Stature in a Puerto Rican Kindred. Possible DJ1 deletion?

    K. Celis, J. Vance, A. Vinuela (Miami, FL, USA)

    Objective: We aim to identify and describe the clinical phenotype associated with a Puerto Rican family with early-onset PD and short stature.  Background: As few…
  • 2017 International Congress

    Improving Diagnosis and Treatment of Anxiety in Parkinson’s Disease: IDATA-PD Study

    N. Dissanayaka, N. Pachana, J. O'Sullivan, R. Marsh, P. Silburn, E. White, E. Torbey, D. Pye, L. Mitchell, J.H. Yang, T. Au, G. Mellick, D. Copland, A. Toft, G. Byrne (Brisbane, Australia)

    Objective: We investigated PD-specific features of anxiety for clear conceptualisation, and assessed targeted psychotherapy for anxiety in Parkinson’s disease (PD). Background: Anxiety is poorly diagnosed in PD…
  • 2017 International Congress

    Neurological examination of motor Functional Neurological Disorders: an evidence-based review towards the development of consensus guidelines from the Committee on Research of the ANPA

    S. Aybek, D. Perez, W.C. LaFrance, C. Stephen, R. Shura, S. Glass, S. Ducharme, V. Voon (Bern, Switzerland)

    Objective: To develop evidence-based consensus recommendations for the neurological examination of motor Functional Neurological Disorders (FND)/Conversion Disorder, weakness and abnormal movements, on behalf of the…
  • 2017 International Congress

    Factors associated with occurrence of motor complications among Parkinson’s disease patients with levodopa treatment in Estonia

    L. Kadastik-Eerme, N. Taba, T. Asser, P. Taba (Tartu, Estonia)

    Objective: To identify the factors associated with the occurrence of motor complications among patients with Parkinson’s disease (PD) who receive levodopa treatment. Background:  Levodopa is the…
  • « Previous Page
  • 1
  • …
  • 139
  • 140
  • 141
  • 142
  • 143
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • An atypical and interesting feature of Parkinson´s disease
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley